CXCL9 and pulmonary fibrosis: Our findings are consistent with the suppression of CXCL-9 by IL-22 in an animal model of lung fibrosis which limited recruitment of CD4+CXCR3+ T cells and attenuation of lung inflammation and fibrosis (32).